Status:
RECRUITING
ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection
Lead Sponsor:
University Hospital, Ghent
Conditions:
Skin Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this project is to assess whether a specific smartphone application (Skinvision App®) can be used as a tool to preselect skin lesions suspicious for skin cancer that require urgent medical ...
Detailed Description
Skin cancer is the most frequent cancer diagnosed and its incidence will keep on rising in the next decade. Early detection and treatment are key to improve both morbidity and mortality, and to decrea...
Eligibility Criteria
Inclusion
- Patients with one or two lesions meeting at least one of the following criteria:
- New mole in an adult (\> 18 years old);
- 'Ugly duckling' sign (i.e. mole that looks different from other moles in the same person)
- Changing mole (size, color, shape or structure);
- Rapid growing lesion
- Non-healing lesion
- Written informed consent of the patient
Exclusion
- Lack of informed consent for study participation
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT05246163
Start Date
January 1 2020
End Date
March 31 2025
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Ghent University Hospital
Ghent, East Flanders, Belgium, 9000